Literature DB >> 19741124

The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination.

Angeliki Mela1, James E Goldman.   

Abstract

In the adult mammalian brain, oligodendrocyte progenitors can differentiate into mature oligodendrocytes during remyelination. Mechanisms that regulate migration and differentiation of progenitors are of great importance in understanding normal development and demyelinating/remyelinating conditions. In a microarray analysis comparing adult and neonatal O4-positive (+) cells, we found that the tetraspanin KAI1/CD82 is far more highly expressed in adult O4(+) cells than in neonatal O4(+) cells (Lin et al., 2009). CD82 is a metastasis suppressor, and its expression is often downregulated or lost in the advanced stages of metastatic cancer. We hypothesized that CD82 could be a factor that restricts migration and promotes differentiation of maturing oligodendrocytes. Western blot analysis of isolated adult O4(+) cells confirms the elevated levels of CD82, which continues to be expressed as these become O1(+) in vitro. In the adult rat white matter, CD82 is coexpressed with CC1 and olig2 but not with NG2 or GFAP. Immature cells of the neonatal forebrain subventricular zone (SVZ) infected in vivo with a retrovirus that constitutively expresses CD82 do not remain immature but differentiate into either CC1(+) and MBP(+) myelinating oligodendrocytes in the white matter or zebrinII(+) astrocytes in the cortex. Their migration from the SVZ is severely restricted. In contrast, downregulation of CD82 in SVZ cells in vivo, using retroviral-expressed short hairpin RNAs (shRNAs), prevents their differentiation into myelinating oligodendrocytes. shRNA-expressing cells remained PDGF receptor alpha positive, olig2(+), or NG2(+) or became CC1(+) nonmyelinating oligodendrocytes or GFAP(+) astrocytes. CD82 thus appears to be a critical molecule in the regulation of oligodendrocyte progenitor migration and myelination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741124      PMCID: PMC2778244          DOI: 10.1523/JNEUROSCI.3075-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

1.  Patterns and dynamics of SVZ cell migration in the postnatal forebrain: monitoring living progenitors in slice preparations.

Authors:  A Kakita; J E Goldman
Journal:  Neuron       Date:  1999-07       Impact factor: 17.173

2.  Overexpression of CD82 on human T cells enhances LFA-1 / ICAM-1-mediated cell-cell adhesion: functional association between CD82 and LFA-1 in T cell activation.

Authors:  N Shibagaki; K i Hanada; H Yamashita; S Shimada; H Hamada
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

3.  Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus.

Authors:  D E Bergles; J D Roberts; P Somogyi; C E Jahr
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

4.  CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production.

Authors:  S Dijkstra; E E Geisert; C D Dijkstra; P R Bär; E A Joosten
Journal:  J Neuroimmunol       Date:  2001-03-01       Impact factor: 3.478

5.  Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter.

Authors:  J M Gensert; J E Goldman
Journal:  J Neurobiol       Date:  2001-08

6.  Aldolase C/zebrin II expression in the neonatal rat forebrain reveals cellular heterogeneity within the subventricular zone and early astrocyte differentiation.

Authors:  S M Staugaitis; M Zerlin; R Hawkes; J M Levine; J E Goldman
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.

Authors:  X Yang; L L Wei; C Tang; R Slack; S Mueller; M E Lippman
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

8.  A novel rat tetraspan protein in cells of the oligodendrocyte lineage.

Authors:  M C Birling; S Tait; R J Hardy; P J Brophy
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

9.  Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.

Authors:  M Ono; K Handa; D A Withers; S Hakomori
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

10.  OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes.

Authors:  S K Tiwari-Woodruff; A G Buznikov; T Q Vu; P E Micevych; K Chen; H I Kornblum; J M Bronstein
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  13 in total

1.  Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.

Authors:  Soad M Saleh; Ranjit S Parhar; Reem S Al-Hejailan; Razan H Bakheet; Hala S Khaleel; Hanif G Khalak; Anason S Halees; Marya Z Zaidi; Brian F Meyer; Gisella P Yung; Jörg D Seebach; Walter Conca; Khalid S Khabar; Kate S Collison; Futwan A Al-Mohanna
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

Review 2.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

3.  TIMP-1 Promotes Oligodendrocyte Differentiation Through Receptor-Mediated Signaling.

Authors:  Alexandra M Nicaise; Kasey M Johnson; Cory M Willis; Rosa M Guzzo; Stephen J Crocker
Journal:  Mol Neurobiol       Date:  2018-08-18       Impact factor: 5.590

4.  Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target.

Authors:  Maya K Desai; Michael A Mastrangelo; Deborah A Ryan; Kelly L Sudol; Wade C Narrow; William J Bowers
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

5.  Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma.

Authors:  Astrid Jeibmann; Kathrin Halama; Hanna Theresa Witte; Su Na Kim; Kristin Eikmeier; Björn Koos; Christian Klämbt; Werner Paulus
Journal:  J Neurooncol       Date:  2015-07-30       Impact factor: 4.130

Review 6.  The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.

Authors:  Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer
Journal:  Glia       Date:  2020-11-30       Impact factor: 7.452

7.  Changes in organelle position and epithelial architecture associated with loss of CrebA.

Authors:  Rebecca M Fox; Deborah J Andrew
Journal:  Biol Open       Date:  2015-02-13       Impact factor: 2.422

8.  The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.

Authors:  Guoyu Lu; Lei Zhou; Xiaohua Zhang; Bo Zhu; Shiwu Wu; Wenqing Song; Xiaomeng Gong; Danna Wang; Yanyan Tao
Journal:  World J Surg Oncol       Date:  2016-10-28       Impact factor: 2.754

9.  CD81 regulates cell migration through its association with Rac GTPase.

Authors:  Emilio Tejera; Vera Rocha-Perugini; Soraya López-Martín; Daniel Pérez-Hernández; Alexia I Bachir; Alan Rick Horwitz; Jesús Vázquez; Francisco Sánchez-Madrid; María Yáñez-Mo
Journal:  Mol Biol Cell       Date:  2012-12-21       Impact factor: 4.138

10.  Effects of Mecp2 loss of function in embryonic cortical neurons: a bioinformatics strategy to sort out non-neuronal cells variability from transcriptome profiling.

Authors:  Marcella Vacca; Kumar Parijat Tripathi; Luisa Speranza; Riccardo Aiese Cigliano; Francesco Scalabrì; Federico Marracino; Michele Madonna; Walter Sanseverino; Carla Perrone-Capano; Mario Rosario Guarracino; Maurizio D'Esposito
Journal:  BMC Bioinformatics       Date:  2016-01-20       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.